Company announcements

Dealings in securities

February 27, 2020

---

Johannesburg. Thursday, 27 February 2020. In compliance with paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information is disclosed:

VESTING IN SHARE APPRECIATION RIGHTS AND SALE OF ORDINARY SHARES BY A PRESCRIBED OFFICER

Name of prescribed officer:	J van Heerden
Nature of transaction:	The off-market issuance of shares to settle SARS
Date of vesting of SARS issued in 2014:	17 November 2019
Date on which SARS issued in 2014 will lapse:	17 November 2020
Number of 2014 SARS vested to date:	15 305
2014 SARS issue value per share:	R18.41
1-day Volume Weighted Average price of shares	R68.1417

Nature of transaction:	On market sale of shares
Date of sale:	25 February 2020
Number of ordinary shares issued to settle 2014 SARS:	11 170
Selling price per share:	R65.5172
Day’s highest sale price:	R67.56
Day’s lowest sale price:	R61.72
Proceeds for total on market sale:	R731 827.12
Class of securities:	Ordinary shares
Nature and extent of prescribed officer’s interest:	Direct beneficial

Prior clearance was obtained in respect of the above dealings by the directors.

For more details contact:

Marian van der Walt
Executive: Investor Relations
+27(0)82 888 1242 (mobile)

Johannesburg, South Africa
27 February 2020

Sponsor:
J.P. Morgan Equities South Africa Proprietary Limited